Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9229-9236
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9229
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9229
ARGs[24] | Signal pathways1 | Reported diseases |
Primary ARGs | ||
CYR61 | Wnt/β-catenin | HCC, pancreatic cancer |
SNAI2 | Epithelial-mesenchymal transition (EMT) | HCC, pancreatic cancer |
FN1 | Cell surface and extracellular matrix | HCC |
ATP1A1 | Na,K-ATPase pump | Pancreatic cancer |
FKBP5 | AKT | Pancreatic cancer |
VEGFA | Angiogenesis | HCC, pancreatic cancer |
SGK | Serine/threonine kinase | HCC, pancreatic cancer |
SLC22A3 | Organic cation transporter | HCC, pancreatic cancer |
NDRG1 | P53/N-myc | HCC, pancreatic cancer |
NFKBIA | NF-κB inhibitory family | HCC |
PYGB | Glycogen catabolism | HCC, pancreatic cancer |
ARGs lacking AREs | ||
ADAMTS1 | Inflammatory process | HCC, pancreatic cancer |
CXCR7 | Orphan G-protein coupled receptor | HCC, pancreatic cancer |
GATA2 | Transcription factor | Pancreatic cancer |
MYC | Oncogene | HCC, pancreatic cancer |
KLF4 | Cell proliferation | HCC, pancreatic cancer |
- Citation: Kanda T, Jiang X, Yokosuka O. Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers. World J Gastroenterol 2014; 20(28): 9229-9236
- URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9229.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9229